期刊文献+

胃癌中COX-2与P-gp表达及其预后的研究 被引量:7

Expression of COX-2 and P-gp and Its Prognosis in Gastric Carcinoma
下载PDF
导出
摘要 目的探讨环氧化酶-2(COX-2)与P-糖蛋白(P-gp)在胃癌组织中的表达及其临床意义。方法应用免疫组化SP法检测COX-2和P-gp在60例胃癌组织中的表达情况。结果全组COX-2阳性率为63.3%(38/60),P-gp阳性率为68.3%(41/60)。COX-2的表达与组织分化程度、浸润深度、淋巴结转移和临床TNM分期相关(P<0.05);P-gp的表达与浸润深度、淋巴结转移和临床TNM分期相关(P<0.05)。COX-2和P-gp同时表达、单独表达及不表达时,胃癌的组织分化程度、病变浸润深度(T分期)、淋巴结转移(N分期)和临床分期组间差异有统计学意义(P<0.05)。COX-2和P-gp在胃癌组织中的表达具有相关性(r=0.374,P=0.004)。胃癌患者1、3、5年生存率分别为83.3%、40.0%和30.0%;COX-2阳性组和COX-2阴性组的1、3、5年生存率分别为79.0%、28.9%、15.8%和90.9%、59.1%、54.6%,两组间差异有统计学意义(χ2=7.885,P=0.005)。结论在胃癌组织中COX-2参与了P-gp的表达调控。COX-2的表达可能成为影响胃癌生存的重要预测因子。 Objective To investigate the clinical significance of Cyclooxygenase - 2 ( COX - 2 ) and P - glycoprotein ( P - gp) expressions in Gastric Carcinoma. Methods The expressions of COX - 2 and P - gp of gastric carcinoma tissue were detected by SP immunohistochemical in 60 cases. Results The positive rates of COX - 2 and P - gp were respectively 63.3% (38/60) and 68.3% (41/60) in the whole group, Some significant correlations were observed between the expression of COX - 2 and the clinical factors including degree of differentiation ( Uc = 3 . 582, P = 0. 000), depth of invasion ( Uc = 3. 084, P = 0. 002), lymphatic metastasis ( Uc = 2. 570 P = 0. 010) and TNM staging (χ^2 = 7. 552, P = 0. 006 ) ; And there was significant correction between the expression of P - gp and the clinical factors including depth of invasion ( Uc = 2. 448, P = 0. 014), lymphatic metastasis ( Uc = 2. 547, P = 0. 011 ) and TNM staging (χ^2 = 5. 396, P = 0. 020). Significant difference was found in degree of differentiation, depth of invasion, lymphatic metastasis and TNM staging when COX - 2 and P - gp repectively in simultaneous expressions, individual expressions and no expressions ( P 〈 0. 05 ). The expression of COX - 2 was in significant correlation with that of P - gp in gastric carcinoma ( r = 0. 374, P = 0. 004). The overall survival rates of 1, 3, 5 years were respectively 83.3%, 40. 0% and 30. 0% in the whole group; And in COX - 2 positive group they were respectively 79.0% , 28.9%, 15.8% and in COX -2 negative group were 90. 9%, 59. 1% , 54.6% , and there was significant difference in survival rates between the two groups (χ^2= 7. 885, P = 0. 005). Conclusion COX - 2 is involved in adjustment of P - gp expression in gastric carcinoma. COX -2 expression may be used as an important survival predictor in gastric carcinoma.
出处 《中国全科医学》 CAS CSCD 2008年第4期291-294,共4页 Chinese General Practice
关键词 胃肿瘤 COX-2 P-GP 多药耐药 预后 Gastric carcinoma Cyclooxygenase-2 P-glycoprotein Multidrug- resistance Prognosis
  • 相关文献

参考文献2

二级参考文献7

  • 1冯久贤,王恩忠,杨友华,李春海.谷胱甘肽S转移酶在进展期胃癌中的表达及意义[J].实用肿瘤杂志,1995,10(1):31-33. 被引量:7
  • 2Patti R, Gumired K, Reddanna P, el al. Overexpression of cyclooxygenase-2 ( COX 2 ) in human primitive neuroectodermal tumors: effect of celecoxib and rofceoxib[J] . Cancer Lett,2002,180(1):13-21.
  • 3Davis T W, Zweifel B S, O'Ncal J M, et al. Inhibition of COX-2 by Celecoxib Reverses Tumor Induced Wasting[J].J Pharmacol Exp Ther,2004,308(3):929-934.
  • 4Agarwal B. Swaroop P, Protiva P, et al. COX 2 is needed but not suffieient for apoptosis induced by COX 2 selective inhibitors in colon cancer cells[J]. Apoptosis,2003,8(6):649-654.
  • 5Sorokin A . Cyclooxygenaae 2: potential role in regulation of drug effluxand multidrug resistance phenotype[J]. Curr Pharm Des,2004,10(6):647-657.
  • 6Krysan K, Merchant F H, Zhu L, el al. COX-2-dependent stabilization of survivin in non-small cell lung cancer[J]. FASEB J,2004.18(1):206-208.
  • 7Barnes N. Haywood P, Flint P. et al. Survivin expression in in situ and invasive breast cancer relates to COX 2 expression and DCIS recurrence[J].Br J Cancer,2006,94(2):253-258.

共引文献25

同被引文献62

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部